Cellution Biologics acquires SimpliDerm®, expanding its human tissue portfolio and entering the U.S. reconstructive surgery market.
Finance GlobalNewswire Aug 18, 2026
Cellution Biologics acquires SimpliDerm®, expanding its human tissue portfolio and entering the U.S. reconstructive surgery market.
Cellution Biologics acquires SimpliDerm®, expanding its human tissue portfolio and entering the U.S. reconstructive surgery market.
Finance GlobalNewswire Aug 18, 2026